Bioactivity:

P276-00 is a novel CDK1, CDK4 and CDK9 inhibitor with IC50 of 79 nM, 63 nM and 20 nM, respectively. Phase 2/3.

CAS nr:

920113-03-7

Purity:

98%

Molecular Weight:

438,3

SMILES:

Cl.CN1CC[C@H]([C@@H]1CO)C1=C(O)C=C(O)C2=C1OC(=CC2=O)C1=C(Cl)C=CC=C1

Formula:

C21H20ClNO5�HCl

Pathway:

Cell Cycle/Checkpoint,Apoptosis

Target:

CDK,Apoptosis